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Material and Methods: An open label, non-comparative, multi-
centric, post marketing observational study was conducted in >18
years of patients with ST elevated myocardial infarction (STEMI)
receiving Retelex. All patients received 20 units Retelex within 6
hours after the onset of acute myocardial infarction (AMI) symp-
toms. The dose was given as two 10 unit Intravenous injections
each over two minutes 30 minutes apart.
Evaluation criteria: Patients were followed on day 1, 3, 5/7 and 30.
The primary evaluation criteria was total number of patients
showing clinically successful thrombolysis based on 50% resolu-
tion of ST-elevation in the maximum affected ( adjacent) leads
within 90e120 minutes of initiation of Reteplase and resolution of
chest pain. Secondary evaluation criteria included LV function by
2D echo after 24 hrs and within 7 days after thrombolysis, per-
centage of patient requiring rescue PCI, percentage of patient
underwent angioplasty or CABG after thrombolysis. Door to nee-
dle time was also recorded in patients receiving the study drug.
Global assessment of efficacy and safety was done by patient as
well as investigator. All adverse events were recorded for safety
assessment.
Results: A total of 228 patients were enrolled out of which 140
were having diabetes mellitus. Out of all patients, 68.9% had ST
elevated anterior wall myocardial infarction. Resolution of 50% of
ST elevation and resolution of chest pain was reported in 90.50%
and 95.4% patients respectively. ). No significant difference was
seen in primary efficacy variables between diabetes versus non-
diabetes patients (p ¼ 0.1538 for 50% ST elevation resolution, p ¼
0.4031 resolution of chest pain). Themean LV function by 2 D echo
after 24 hours and within 7 days after thrombolysis was 46.79
(+9.33). Rescue PCI was required by 7.6 % patients while angio-
plasty and CABGwas done in 22% and 16.8% patients respectively.
No significant difference was seen in diabetes versus non-dia-
betes patients requiring rescue PCI (p ¼ 0.1059), angioplasty (p ¼
0.2172) and CABG (p ¼ 0.9128). The incidence of adverse event in
this study was 5.3%.
Conclusion: Reteplase IV Injection-recombinant plasminogen
activator is effective and well tolerated in the management of ST
elevated myocardial infarction (STEMI) in Indian patients
including diabetes patients.
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Background: The association between overt hypothyroidism and
coronary artery disease has been often observed in many studies.
Less evident is the data on asymptomatic hypothyroidismwithout
clinical manifestations and with mild elevation of thyroid stim-
ulating hormone.
Methods: It is a prospective observational study of about 1200
patients with Ischemic heart disease. 240(20%) patients were
observed to have Hypothyroidism. Consecutive 75 (31.25%) pa-
tients with hypothyroidism and ischemic heart disease was
analyzed for the present study.
Results: Incidence of Hypothyroid patients among 1200 Ischemic
Heart Disease patients who were admitted in our centre during a
period of 18 months from 1st August 2012 after satisfying the
exclusion criteria was 75(6.25%) 31 males & 24 females. Newly
detected cases of hypothyroidism was 22(29.3%)13 males & 9 fe-
males, of which 12 patients was diagnosed as subclinical hypo-
thyroidism and was initiated treatment and self reported cases of
Hypothyroidism was 53(70.6%) 27 males & 26 females.
Out of the 22 newly reported cases of Hypothyroidism 14(63.6%)
patients had elevated levels of total cholesterol(>200 mg/dL),
LDL(>150), HDL(<40 mg/dL, triglycerides(>150mg/dL) for which
statin therapy was initiated and 5 (22.7%) patients was on statin
therapy for dyslipidemia with normal levels of lipid profile and
with average statin dose of 20 mg daily. 3 patients had normal
values of total cholesterol, LDL, HDL, triglycerides.
Site of coronary artery lesion in self reported case of hypothy-
roidism in ischemic heart disease patients was LAD-32.08%, LCX-
26.42%, RCA-15.09%, and others-3.77%. Site of coronary artery
lesion in newly detected case of hypothyroidism in ischemic heart
disease patients was LAD-40.91%, RCA-22.73, LCX-13.64% and
others-4.55%. PTCA was done in 78.7%% of the patient under
study, medical management and follow up initiated in 18.7% and
CABG in 2.6% patients.
Conclusion: The incidence of hypothyroidism among our study
populationwith ischemic heart diseasewas 6.25%. In self reported
cases of reported cases of Hypothyroidism, 43.4% of patients was
on stain therapy for Dyslipidemia and 30.18% patients was diag-
nosed as new cases of Dyslipidemia. In newly reported cases of
hypothyroidism 63.6% patients was diagnosed as new cases of
Dyslipidemia. LAD lesion(44%) was dominating in both self re-
ported and newly detected cases of hypothyroidismwith ischemic
heart disease.
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Background: High levels of mean platelet volume (MPV) may be
associated with adverse outcomes in patients with myocardial
infarction (MI). We examined the association between MPV and
the risk of death and adverse cardiovascular outcomes in patients
with MI.
Methods: We studied consecutive patients with MI admitted to a
tertiary care hospital during a period of 1year. MPV was measured
at admission and at third month. Patients were followed-up for
one-year primary composite outcome of cardiovascular death,
stroke, fatal or nonfatal MI and cardiac failure. Patients were
classified according to tertile of baseline MPV.
Results: A total of 1206 MI patients, including 934 males (77.4%)
and 272 females (22.6%) were studied. The mean age of the study
population was 55.93 ± 11.07 years. At one-year follow-up, 292
(28.57%) primary outcome occurred: cardiovascular mortality 78
(7.6%), fatal or nonfatal MI 153 (15.0%), stroke 30 (2.9%), and car-
diac failure 128 (12.52%). Highest tertile MPV patients had higher
primary outcome as compared with those with MPV in the lowest
tertile (adjusted OR ¼ 1.70; 95% CI: 1.18 to 2.45; p ¼ 0.01). Total
mortality was also more in high MPV group (adjusted OR 2.83; 95%
CI: 1.49 to 5.35; p < 0.001). There were no significant changes in
meanMPV values at admission from those at thirdmonth interval
(9.15 ± 0.99 Vs 9.19 ± 0.94; p ¼ 0.2).
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